Economic vs Patient Safety Credentialing: The Standard Is "Exclusively," and Nobody Cites It

Section 809.05 says a governing body and the medical staff shall act exclusively in the interest of maintaining and enhancing quality patient care. Exclusively. That standard governs every credentialing decision, has no enforcement mechanism attached, and is almost never invoked — while physicians facing a matter that could be characterized either way reliably argue for the framing that gives them fewer rights.

A physician stops being able to practise at a hospital. Sometimes a committee sat, findings were written, and a hearing was available. Sometimes a contract was awarded elsewhere and nothing happened at all. From outside, and frequently from inside, the two look the same.

They are not the same. One produces procedural entitlements and a permanent regulatory record; the other produces neither. And which route a matter takes is determined by how it is characterized — in documents, early, usually without the physician’s participation.

Governing all of it is a sentence that deserves more attention than it gets. Section 809.05 (official source) requires that a governing body and the medical staff act exclusively in the interest of maintaining and enhancing quality patient care.

This article maps the boundary: what each route does, why physicians argue for the wrong one, where utilisation and quality genuinely overlap, what the immunity framework rewards, and what a physician should document whichever way a matter goes.

The statutory standard nobody quotes

There is a sentence in the California peer review scheme that ought to be the starting point of every credentialing dispute and is almost never cited.

Section 809.05 (official source) provides that a governing body and the medical staff shall act exclusively in the interest of maintaining and enhancing quality patient care.

Read the adverb. Not primarily, not substantially, not among other considerations. Exclusively.

That is a demanding standard, and it sits in the same section that declares it the policy of this state that peer review be performed by licentiates and that bounds the governing body’s role — great weight to peer review body actions, no arbitrary or capricious conduct, consultation before directing an investigation, written notice before acting directly.

The practical significance is that the scheme supplies a purpose test. An action taken for reasons other than maintaining and enhancing quality patient care is not merely unfair; it is in tension with the statutory standard governing the bodies that took it.

That does not make every economically motivated decision unlawful, and this article does not argue that it does. Institutions make legitimate economic decisions constantly — about contracts, service lines, staffing, and exclusive arrangements — and most sit entirely outside the peer review scheme.

The question this article addresses is narrower and more consequential: what happens when an economic decision is routed through the peer review apparatus, or when a peer review process is influenced by economic considerations. That is where the exclusivity standard bites, and where physicians most often fail to invoke it.

Two decisions that look identical from outside

A physician loses the ability to practise at an institution. From the outside, and often from the inside, the mechanism is invisible — but the legal consequences diverge sharply.

Route one: the economic decision. An exclusive contract is awarded elsewhere, a service line closes, a group loses a contract, a department is restructured, an employment agreement is not renewed. The physician’s privileges may remain formally intact while the practical ability to use them disappears. No committee sits, no findings are written, no hearing is available, and — ordinarily — no reporting duty attaches, because no action was taken against privileges for a medical disciplinary cause or reason.

Route two: the peer review action. A concern about competence or professional conduct is examined, findings are written, a proposed action crystallises, hearing rights attach under the section 809 scheme, and a report follows under section 805 (official source) if the enumerated conditions are met.

The physician experiences both as being pushed out. The consequences are not comparable.

Route one is professionally survivable in a way route two frequently is not. There is no report, no regulatory referral, and no permanent record for a credentialing committee to read. What there is instead is an unexplained departure and a gap.

Route two produces a permanent, queryable record — and procedural entitlements that route one does not offer.

Which means physicians face a genuinely difficult judgment when a matter could go either way, and the judgment is usually made without the distinction in view.

Why physicians misjudge the choice

Faced with a matter that could be characterized either way, physicians reliably reason toward the wrong preference, and the reasoning is understandable.

The intuition is that a clinical characterization is an accusation about competence and therefore the more damaging one. An administrative or economic framing sounds neutral sounds safer.

Three things are wrong with that.

The statutory hearing entitlement attaches to the clinical characterization, not the administrative one. Where the proposed action is based on a medical disciplinary cause or reason, the entitlements in section 809.3 (leginfo.legislature.ca.gov) apply — all information made available to the trier of fact, a record of the proceedings, the right to call and cross-examine witnesses, and a written closing statement. An administrative framing may deliver none of that, leaving the physician with whatever the bylaws happen to give.

The federal reporting analysis does not follow the label. Whether the arrangement involved a surrender or restriction of privileges while an investigation was open is a question about privileges, governed by 42 U.S.C. § 11133 (law.cornell.edu) — not answered by characterizing the dispute as economic.

And an unexplained departure is not neutral at future credentialing. A committee reading a gap with no adjudicated record constructs an explanation, and institutional caution constructs an unflattering one.

So the preference physicians express — keep it administrative — frequently trades real procedural protection for an imagined reputational benefit, while leaving reporting exposure untouched.

When economics enters a clinical process

The harder case is not the openly economic decision. It is the clinical process in which economic considerations are present but unstated.

Recognisable patterns include: concerns arising shortly after a physician joins a competing group or opens an independent facility; utilisation-based criticism framed as quality concern; review triggered by referral patterns rather than by outcomes; and matters arising during contract negotiation or immediately after a contract is lost.

None of those establishes improper motive. Clinical concerns can coincide with economic conflict, and a genuine concern is not disqualified by inconvenient timing. Treating coincidence as proof is a mistake physicians make often, and it damages credibility when the argument is tested.

But the exclusivity standard in section 809.05 (official source) is the provision that speaks to this, and it is worth invoking properly rather than rhetorically. The bodies are required to act exclusively in the interest of maintaining and enhancing quality patient care.

Invoking it properly means documentary, not motivational, argument. What is the clinical basis, in the findings? Is the concern supported by outcomes or by utilisation data? Were comparable cases involving other physicians reviewed? What was the timing relative to the economic event, established by dates rather than by inference? Who raised the concern, and what is their relationship to the economic matter?

Those are answerable from documents and dates. An argument built from them is testable. An argument built from asserted motive is not, and it invites the record to become about the physician’s conduct during the process — which is itself a reportable basis under section 805 (leginfo.legislature.ca.gov).

Employment, ownership, and the third route

This article has described two routes. For a growing share of physicians there is a third, and it is the one that produces the most confusion.

Where a physician is employed — by the hospital, an affiliated foundation, or a medical group holding a contract — the employment relationship is a separate legal channel from both peer review and institutional contracting. It can be terminated on its own terms, on notice, sometimes without cause, with no committee and no findings.

That creates a specific hazard. A matter that would require peer review if pursued as a privileges action can be resolved as an employment termination instead. The institution achieves its outcome faster; the physician avoids a report; and the underlying question is never adjudicated.

Three things survive that route, and physicians routinely discover them late.

Privileges may remain formally intact and practically unusable, with a renewal cycle that will ask why they were not exercised.

The federal analysis under 42 U.S.C. § 11133 (official source) follows privileges rather than employment. Whether the arrangement involved a surrender or restriction of privileges while an investigation was open is not answered by an employment agreement, however carefully drafted.

And the separation agreement is usually drafted by employment counsel. Where that counsel has not read the bylaws and does not know that privileges and employment are distinct relationships, the agreement can create the reportable event it was meant to avoid — the failure examined in resignation during investigation (Resignation During Investigation: The Exit That Creates the Record).

The question to insist on, in writing, before signing anything: what does this agreement do to my privileges, and does anything in it constitute a surrender or restriction?

Utilisation, quality, and the boundary between them

The most contested territory is where utilisation and quality genuinely overlap, because the overlap is real rather than pretextual.

A physician whose practice is materially more resource-intensive than peers may be delivering worse care, better care, or the same care to a different case mix. Length of stay, imaging volume, implant selection, operative time, and readmission all carry both quality and cost signal, and separating them requires case-mix adjustment that institutional data frequently cannot support.

The scheme acknowledges the legitimacy of utilisation review. Section 510 (official source) addresses peer review and utilisation review protocols, referring expressly to a hospital medical staff, a hospital governing body acting pursuant to section 809.05, and payers enforcing reasonable protocols and determining whether a practitioner has complied with them.

So utilisation review is not illegitimate. The questions are what it is being used for whether the analysis supports the conclusion drawn.

Four tests are worth applying to any utilisation-based concern. Is the comparison risk-adjusted, and against what peer group? Is the sample large enough to distinguish signal from variation? Is the metric one with an established relationship to outcomes, or merely to cost? And has any outcome difference been demonstrated, as distinct from a resource difference?

A concern that survives those tests is a quality concern and should be engaged as one. A concern that fails them is a cost observation wearing clinical language — and the exclusivity standard is the provision that addresses it.

Physicians who cannot articulate this distinction end up either dismissing legitimate quality signal or accepting cost criticism as clinical judgment. Both are avoidable.

Exclusive contracts and the closed department

Exclusive contracting is common, legitimate, and the mechanism by which many physicians lose practice access without any peer review process at all.

An institution may contract with a single group for a service — anaesthesia, radiology, emergency medicine, pathology, hospitalist services are typical. Physicians outside that group cannot practise in the department regardless of their credentials, and the arrangement is generally an institutional business decision rather than a peer review matter.

The consequences for an affected physician are specific.

Privileges may remain but become unusable. That produces the awkward position of holding privileges that cannot be exercised, and a renewal cycle that will eventually require an answer about why they were not used.

Hearing rights ordinarily do not attach, because no action was taken against privileges for a medical disciplinary cause or reason. The section 809 scheme is not engaged.

And — importantly for the physician’s later position — there is usually no report. This is the one respect in which the economic route is genuinely preferable, and it is worth recognising rather than resenting.

What is worth establishing at the time, in writing: that privileges were not restricted, that no concern about competence or conduct was involved, and that the change resulted from a contracting decision. That documentation is what answers a credentialing question five years later, and it is easy to obtain at the time and impossible to reconstruct afterward.

The error physicians make here is treating an exclusive-contract exclusion as an insult to be protested rather than a fact to be documented. The protest achieves nothing; the documentation is worth years.

The mixed case, and how to keep it separate

The most damaging scenario is the one in which both routes are live: an economic dispute is underway and a clinical concern is raised.

The risk is conflation — and it runs in both directions.

A physician who responds to a clinical concern by arguing that the real motive is economic has answered a question the process is not asking, and has generated a record in which they appear to be deflecting rather than addressing findings. The clinical concern remains on the record, unanswered.

An institution that resolves a clinical concern through an economic mechanism — declining to renew a contract rather than completing a peer review process — may leave the underlying question unaddressed and, depending on what happened to privileges, may still be inside the federal reporting analysis under 42 U.S.C. § 11133 (law.cornell.edu).

The discipline required of the physician is to run two responses in parallel and keep them separate.

On the clinical concern: answer it on the merits, with documents, in the process provided. Address the findings as written. Do not argue motive here.

On the economic matter: pursue it in the forum that governs it — contract, employment, or business dispute — with counsel appropriate to that.

And on the interaction: establish in writing which process is being used for what, and specifically what is happening to privileges under any proposed resolution. That question is the one that identifies reporting exposure, and it is the question a purely economic negotiation will not raise on its own.

What the immunity framework rewards

A structural feature explains institutional behaviour better than any account of motive, and physicians can use it.

42 U.S.C. § 11112 (official source) conditions federal immunity for professional review actions on standards: that the action was taken in the reasonable belief it furthered quality health care, after a reasonable effort to obtain the facts, after adequate notice and hearing procedures or such other procedures as are fair to the physician under the circumstances, and in the reasonable belief the action was warranted by the facts.

Note what that protects. A professional review action taken in the reasonable belief that it furthers quality health care. An action taken for economic reasons and dressed as peer review does not obviously satisfy the first element, and an institution’s counsel knows it.

Two consequences follow that favour the physician.

Institutions have a reason to keep economic decisions out of the peer review apparatus, because routing them through it forfeits the framing that immunity depends on. Where an institution has nonetheless used peer review for an economic purpose, it has created a vulnerability in its own position.

And institutions have a reason to run defensible procedure, because immunity turns partly on notice and hearing adequacy. Procedural requests therefore ask for something the institution needs — which is why they are granted more readily than substantive ones.

The practical instruction: ask for procedure, document everything, and let the institution’s own interest in a defensible record do some of the work.

Credentialing criteria that are not about competence

Some credentialing requirements have no clinical content, and physicians frequently assume they are unchallengeable.

Common examples: board certification requirements beyond licensure, minimum case volumes, geographic proximity or residence requirements to maintain an office within a defined radius, exclusive-loyalty or non-competition conditions, and participation requirements tied to call or administrative service.

Some of these have genuine quality rationales. Volume requirements can correlate with proficiency. Proximity requirements can bear on availability for emergencies. Certification can be a proxy for currency of knowledge.

Others function primarily to restrict competition or to bind physicians to an institution, and the exclusivity standard in section 809.05 (leginfo.legislature.ca.gov) — that a governing body and the medical staff shall act exclusively in the interest of maintaining and enhancing quality patient care — is the provision that speaks to the distinction.

The useful question for any criterion is empirical: what is the evidence that this requirement bears on quality of care in this setting, and does the requirement apply uniformly?

A criterion supported by evidence and applied uniformly is a quality requirement. A criterion applied selectively, or with no articulable relationship to outcomes, invites the exclusivity question.

This matters most at the application stage, and applicants are the group least positioned to raise it — they bear the burden under section 809.3 (leginfo.legislature.ca.gov) of persuading the trier of fact of their qualifications, and they have no relationship capital to spend. The practical advice is to ask, in writing and before applying, what the criteria are how they are applied. The answer is a document.

The bylaws dimension

Because the Legislature directed that implementing provisions sit in medical staff bylaws, the boundary between economic and clinical decisions is partly drawn there.

Section 809 (official source) records the intent that written provisions implementing sections 809 to 809.8 in the acute care hospital setting be included in medical staff bylaws, adopted by a vote of the members of the organized medical staff and subject to governing body approval, which shall not be withheld unreasonably.

So a medical staff can, by vote, address this boundary in its own governing documents. Provisions worth arguing for include: a requirement that any adverse action state whether it is based on a medical disciplinary cause or reason; a requirement that concerns arising within a defined period of a contractual or economic event be documented as such; a provision confirming that exclusion by exclusive contract is not an adverse action for reporting purposes and will be documented accordingly; and a requirement that utilisation-based concerns be presented with case-mix adjustment and a stated peer comparison group.

Each of those is procedural rather than substantive, which is why each is achievable. None asks the institution to give up an economic prerogative; each asks that the basis be stated.

And additional bylaws provisions bind. Within the scheme, parties are bound by additional notice and hearing provisions in medical staff bylaws which are not inconsistent with sections 809.1 to 809.4 — the provision compiled at section 809.6 (hortyspringer.com).

The moment to do this is when nothing is at stake, as argued in medical staff bylaws as a source of rights (Medical Staff Bylaws as a Source of Rights: The Document Nobody Reads Until It Governs Them). A physician raising it during their own matter will be heard as arguing their case.

What the record should show

Whichever route a matter takes, the documentary position determines what a physician can say about it later.

Where the outcome is economic, the record should establish four things: that no action was taken against privileges; that no concern about competence or professional conduct was involved; that the change resulted from a contracting, employment, or business decision; and the dates. A short letter confirming those points is easy to obtain at the time and worth years of easier answers afterward.

Where the outcome is clinical, the record should include the committee’s written findings, whatever was disclosed under section 809.3 (official source), the transcript if there was a hearing, and the physician’s written closing statement.

Where both were live, the record should establish which process produced which outcome. This is the situation in which a physician most needs contemporaneous documentation and least often has it, because attention goes to the immediate dispute.

The access asymmetry applies throughout. Evidence Code section 1157 (leginfo.legislature.ca.gov) shields peer review proceedings and records from discovery, and Arnett v. Dal Cielo (1996) 14 Cal.4th 4 (law.justia.com) holds that a Medical Board investigative subpoena is not "discovery" within that section — so the file is reachable by the regulator and largely closed to the physician outside a hearing.

Which means the physician’s own file is not a supplement to the institutional record. In most matters it is the only record the physician will ever hold.

Peer review as a competitive instrument

The concern that peer review can be misused competitively is old, real, and frequently overstated — and being precise about it improves a physician’s position.

The structural conditions are genuinely present. Peer review is conducted by licentiates, who in a given specialty at a given institution are frequently the physician’s direct competitors. California courts have described the process as one in which a committee of licensed medical personnel evaluates applicants and assesses the performance of physicians on staff — the account in Kibler v. Northern Inyo County Local Hospital District. Colleagues assessing colleagues is the design, not a defect.

What constrains misuse: the requirement in section 809.05 (official source) that both the governing body and the medical staff act exclusively in the interest of maintaining and enhancing quality patient care; the conflict-objection provisions in the bylaws; the immunity conditions in 42 U.S.C. § 11112 (official source), which turn on reasonable belief that the action furthered quality health care and on a reasonable effort to obtain the facts; and the disclosure entitlement in section 809.3 (official source), which forces the institution’s evidence into view.

What a physician should actually do with the concern is narrower than what they usually do. Raise conflict through the bylaws objection procedure, within its window, identifying the specific relationship. That is a procedural argument with a procedural remedy — panel composition — and it is available.

What not to do is frame the whole matter as competitive persecution. It is not testable, it invites a record about the physician’s conduct during the process, and it displaces the documentary arguments that work.

How this reaches the licensing system

Economic and clinical routes reach the regulator differently, and the difference is worth stating plainly.

The clinical route reaches it directly. Where an enumerated action is taken for a medical disciplinary cause or reason, section 805 (official source) requires a report, and section 805.01 (official source) requires filing within 15 days of final proposed action regardless of whether a hearing is held. The Medical Board (official source) then conducts its own inquiry on its own standard.

The economic route ordinarily does not. An exclusive contract award, a service line closure, or a non-renewal is not an action against privileges for a medical disciplinary cause or reason, and no report follows.

Two qualifications matter.

Where an economic mechanism is used to resolve a matter in which an investigation was open, the federal analysis under 42 U.S.C. § 11133 (law.cornell.edu) may still be engaged — because that limb turns on what happened to privileges and whether an investigation was open, not on the commercial framing.

And where privileges were restricted as part of an economically motivated arrangement, the state enumerated categories may be engaged regardless of the parties’ characterization.

So the economic route is not a reporting-free zone. It is a route that ordinarily avoids reporting, and the ordinarily is doing real work. The question that resolves it is always the same one: what happened to privileges, and was an investigation open.

What this looks like from the institution’s side

Institutions are not usually choosing between routes cynically, and understanding the actual decision improves a physician’s response.

An institution facing a problem with a physician has a genuine allocation question. If the concern is clinical, the peer review process is the required route and the immunity framework rewards using it properly. If the matter is contractual or economic, the peer review process is the wrong instrument — slower, more expensive, more disclosure-exposed, and outside the framing that 42 U.S.C. § 11112 (law.cornell.edu) protects.

So institutional counsel frequently advises keeping economic matters out of peer review for the institution’s own reasons. That advice happens to align with the physician’s interest in not acquiring a report, and physicians rarely recognise the alignment.

Where the interests diverge is on procedure. An institution resolving a matter economically avoids a process; a physician facing a clinical concern wants the process because it produces disclosure and a record.

And where they diverge most sharply is on documentation. An institution has little reason to write a letter confirming that no clinical concern was involved. A physician has every reason to want one. That asymmetry is why the request must be made — explicitly, in writing, and while the institution still wants the matter concluded amicably.

That last point is the practical one. The moment of maximum leverage for obtaining documentation is the moment before a resolution is finalised, and it is the moment physicians are least focused on paperwork.

The structural critique worth making

Four observations about a scheme whose allocation is defensible and whose boundary is under-policed.

The exclusivity standard has no enforcement mechanism attached to it. Section 809.05 (official source) requires that a governing body and the medical staff act exclusively in the interest of maintaining and enhancing quality patient care. Nothing in the section provides a remedy to a physician who believes it was not observed, and nothing requires that the basis for an action be stated in a form that would let anyone test it.

The two routes offer sharply different procedural protection for outcomes that are equivalent in practical effect. A physician excluded by exclusive contract loses practice access with no process; a physician facing a clinical concern gets a hearing. Whether that difference is justified depends on a view about the nature of the loss, and the scheme does not articulate one.

The utilisation-quality boundary is drawn by whoever writes the findings. Section 510 (leginfo.legislature.ca.gov) legitimises utilisation review without specifying what analytical standard a utilisation-based quality concern must meet — no case-mix adjustment requirement, no minimum sample, no requirement that an outcome difference be shown.

And the documentation asymmetry runs against the physician. The institution holds the record, the regulator can reach it, the physician largely cannot, and nothing requires the institution to confirm what a departure was not about.

The cheapest available fix is a bylaws provision requiring that every adverse action state whether it rests on a medical disciplinary cause or reason. That single sentence would resolve most of the ambiguity this article describes.

What journalists should ask

Economic credentialing is reported rarely and usually badly, because the two routes are invisible from outside. Five questions separate the stories.

What mechanism produced the outcome? A peer review action, an exclusive contract award, an employment termination, or a non-renewal. These are different events with different records, and a story that does not establish which occurred has not established anything.

Was a report filed? Under section 805 (leginfo.legislature.ca.gov) a report follows an enumerated action taken for a medical disciplinary cause or reason. The presence of a report indicates a clinical characterization; its absence is consistent with an economic route — or with a matter that went unreported.

What did the institution state as the basis, in writing, at the time? Not what participants say afterward. The contemporaneous document is the story.

If a utilisation or quality concern is asserted: what was the risk adjustment, the peer comparison group, and the sample — and was an outcome difference demonstrated or only a resource difference? Section 510 (leginfo.legislature.ca.gov) legitimises utilisation review without setting any analytical standard, so the analysis is the question.

And what were the dates, relative to any contractual or competitive event? Timelines are verifiable; motive is not.

The framing to avoid is the one both sides will offer. Physicians will describe competitive persecution; institutions will describe a quality concern. Both are unfalsifiable as stated. The documentary record — mechanism, basis, analysis, dates — is where the reportable facts are, and the exclusivity standard (leginfo.legislature.ca.gov) is the benchmark against which they can be assessed.

What would fix this

Four changes, in ascending order of difficulty, each addressing a specific defect identified above.

Require every adverse action to state whether it rests on a medical disciplinary cause or reason. This is a bylaws amendment, adoptable by medical staff vote, and it resolves most of the ambiguity in this article. A physician would know which route they were on, which rights attached, and whether a report was coming. It costs a sentence and nobody’s prerogative.

Require utilisation-based concerns to be presented with a stated peer comparison group, case-mix adjustment, and sample size. Also a bylaws provision. It does not prevent utilisation review; it requires that the analysis be shown. Institutions with sound analysis lose nothing.

Require documentation of a non-clinical departure on request. Where a physician’s access ends for contractual or economic reasons, a letter confirming that no action was taken against privileges and no competence or conduct concern was involved costs the institution nothing and saves the physician years of harder answers. Nothing currently requires it.

And attach a remedy to the exclusivity standard. Section 809.05 (official source) requires that both bodies act exclusively in the interest of maintaining and enhancing quality patient care, and provides no mechanism by which a physician can test whether they did. A standard without a remedy shapes conduct only where institutions choose to be shaped. That is a legislative question rather than a bylaws one, and it is the change that would matter most.

The first three are available to any medical staff that wants them, by vote, while nothing is at stake.

A checklist for the ambiguous matter

Where a matter could go either way, the sequence below establishes the position before anything is agreed. It is short because it has to be usable under pressure.

Ask, in writing: is this action based on a medical disciplinary cause or reason? Everything else follows from the answer, and the refusal to answer is itself a document worth holding.

Ask, in writing: what happens to my privileges? Not to my contract, not to my employment, not to my schedule. Privileges. That is the question that determines whether 42 U.S.C. § 11133 (official source) is engaged.

Ask whether an investigation focused on you is open, and whether the body holding decision-making authority has taken final action. If an investigation is open, no exit or restriction should be agreed until the reportability analysis is complete.

Identify the forum for each strand. Clinical concern into the peer review process; contractual or employment matter into its own forum, with counsel competent there.

Request the documents that will exist afterward. Committee findings if there are any; a letter confirming no privileges action and no competence or conduct concern if the outcome is economic. Both are far easier to obtain before a resolution is signed than after.

And record the dates — every economic event, every clinical concern, every communication. Under Evidence Code section 1157 (leginfo.legislature.ca.gov) and Arnett v. Dal Cielo (law.justia.com) the institutional file is reachable by the regulator and largely closed to you outside a hearing, so your own dated record is frequently the only one you will hold.

Six questions, one afternoon. The alternative is answering them from memory in five years.

For medical staff leaders drawing the line

The allocation problem looks different from the chair’s side, and getting it wrong exposes the institution as well as the physician.

Decide the route before the process starts, and record the decision. A matter routed into peer review is a matter in which the institution has asserted a clinical basis — and 42 U.S.C. § 11112 (law.cornell.edu) conditions immunity on a reasonable belief that the action furthered quality health care. Using peer review for a matter that is actually contractual forfeits the framing immunity depends on.

Do not let an economic dispute become a conduct matter by inattention. Protracted disputes generate friction generates conduct observations framed in patient-care terms bring the matter inside section 805 (official source). A leader who sees that happening should name it and separate the strands rather than letting the record drift.

Require the analysis behind a utilisation concern before acting on it. Peer comparison group, case-mix adjustment, sample size, and whether an outcome difference exists. A concern that cannot survive those questions should not be presented as a quality concern, and presenting it anyway is what makes an institution vulnerable.

Apply criteria uniformly, and be able to show it. Selective application of a non-clinical criterion is the fact pattern that draws scrutiny under the exclusivity standard (official source).

And write the letter. Where a physician’s access ends for contractual reasons, confirming in writing that no privileges action was taken and no competence or conduct concern was involved costs nothing, is accurate, and prevents a decade of ambiguity that serves nobody — including the institution, which will be asked about it.

The applicant’s position, which is weakest of all

Everything above assumes an established member of a medical staff. An applicant facing non-clinical criteria is in a materially worse position, and the reasons are worth stating.

The burden runs the other way. Under section 809.3 (leginfo.legislature.ca.gov), initial applicants bear the burden of persuading the trier of fact of their qualifications by a preponderance of the evidence, by producing information which allows for adequate evaluation — while the peer review body carries the initial duty to present evidence supporting a charge against an existing member. An applicant is establishing something, not defending against an allegation.

There is no relationship capital. An established physician raising a question about a criterion is a colleague; an applicant doing so is a problem before they have started.

And the mechanism is opaque from outside. An applicant does not know what criteria are applied, how uniformly, or what weight a non-clinical requirement carries. Denial for failure to satisfy an unstated criterion is difficult to distinguish from denial on the merits.

What is available, and worth doing before applying rather than after: ask in writing what the criteria are, whether any are non-clinical, and how they are applied. A written answer becomes the benchmark against which a later denial can be assessed against the exclusivity standard (official source). A refusal to answer is informative in its own right.

And critically — as set out earlier in this series — do not withdraw an application to avoid a denial while any investigation is open. The instinct is exactly wrong, and withdrawal in those circumstances is itself reportable.

What to do when both routes are live

Establish in writing whether the proposed action is based on a medical disciplinary cause or reason — that determines which route and which rights.

Ask specifically what is happening to your privileges under any proposed resolution, separately from any contractual outcome.

Answer a clinical concern on the merits and in the process provided; do not argue economic motive there.

Pursue an economic matter in the forum that governs it, with counsel appropriate to that.

Test any utilisation-based concern: risk adjustment, peer comparison group, sample size, and whether any outcome difference has been shown.

Where the outcome is economic, obtain a letter confirming no action was taken against privileges and no competence or conduct concern was involved.

Ask, in writing and before applying anywhere, what non-clinical credentialing criteria apply and how they are applied.

Note the dates of every economic event and every clinical concern — the timeline is the only testable form of a motive argument.

Ask for the basis, not the motive

Physicians who suspect an economic motive behind a clinical process usually say so, and it rarely helps. Asserted motive is not testable, the process is not asking about it, and the attempt generates a record in which the physician appears to be deflecting rather than answering findings.

What is testable is the basis. What clinical evidence supports this concern? Is the utilisation comparison risk-adjusted, and against whom? Were comparable cases involving other physicians reviewed? What are the dates, relative to the economic event? Who raised it, and what is their relationship to the commercial matter?

Those questions are answerable from documents, and the answers — or the refusals — do the work that an accusation cannot. The exclusivity standard in section 809.05 is invoked properly by showing that the stated basis does not hold, not by asserting that a different one was operating.

General educational information—not legal or medical advice

This article describes California statutory structure for physicians, medical staff leaders, and health lawyers. It is not legal advice and creates no professional relationship. Whether a particular decision is properly characterized as economic or as a peer review matter is fact-specific, institutional arrangements vary, and the statutes are amended. A physician facing exclusion by either route should obtain individual advice from counsel practicing in medical staff law — and, where a contract is involved, counsel competent in that forum as well.

Questions worth asking

Is this action based on a medical disciplinary cause or reason, and where is that stated?

What happens to my privileges under this proposal, separately from any contract?

If a utilisation concern is raised: what is the risk adjustment, the peer group, and the sample?

Has any outcome difference been demonstrated, or only a resource difference?

Were comparable cases involving other physicians reviewed on the same criteria?

Will the institution confirm in writing that no competence or conduct concern was involved?

Takeaway

California requires a governing body and the medical staff to act exclusively in the interest of maintaining and enhancing quality patient care — a demanding standard with no enforcement mechanism attached. The economic and clinical routes to the same practical outcome carry entirely different procedural rights and reporting consequences, and physicians reliably argue for the administrative framing that gives them less. Invoke the standard through the stated basis, not through asserted motive, and document what a departure was not about while the institution still wants it concluded.

Sources and Authorities

The sources below are provided so readers can confirm the governing text and current agency guidance. Laws, regulations, agency pages, and implementation dates can change; time-sensitive requirements should be checked against the current official source.

California BPC Article 11, §§800–809.9 — leginfo.legislature.ca.gov

California BPC §805 — leginfo.legislature.ca.gov

California BPC §805.01 — leginfo.legislature.ca.gov

California Evidence Code §1157 — leginfo.legislature.ca.gov

42 U.S.C. §11111 — law.cornell.edu

42 U.S.C. §11112 — law.cornell.edu

42 U.S.C. §11133 — law.cornell.edu

NPDB Guidebook — Clinical Privileges — npdb.hrsa.gov

45 C.F.R. Part 60 — ecfr.gov

leginfo.legislature.ca.gov — leginfo.legislature.ca.gov

Case opinion — law.justia.com

www.mbc.ca.gov — mbc.ca.gov